Skip to content
ppharmaranks
Menu
CompaniesProductsDrug classesConditionsBest by conditionTreatmentsInteraction checkerFood & medicinesWhat pharmacies payPill identifierMedicines & breastfeedingChildren’s dosage chartsDo medicines expire?Crushing & splitting pillsHow long meds take to workAlternating Tylenol & ibuprofenDrug recallsSupplementsSafety & lawsuitsGuidesA–ZHow we rate

GEMFIBROZIL vs REPATHA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. GEMFIBROZIL and REPATHA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

gemfibrozilrepatha

Rating

70/100
72/100

Pharmacy pays

~$3.09 /30
—

Type

RX
RX

Active ingredient

GEMFIBROZIL
EVOLOCUMAB

Manufacturer

Cadila Pharms Ltd
Amgen Inc

Dosage forms

Tablet
Injectable

Drug class

Peroxisome Proliferator Receptor Alpha Agonist
—

Boxed warning

None
None

Treats

Coronary Artery Disease, Hypercholesterolemia, Hyperlipoproteinemias
Hypercholesterolemia, Atherosclerosis

Frequently asked questions

Which is better-rated, Gemfibrozil or Repatha?

By our independent rating, Repatha scores higher — 3.6 vs 3.5 out of 5 for Gemfibrozil. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Gemfibrozil and Repatha?

Gemfibrozil contains Gemfibrozil, while Repatha contains Evolocumab — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.